Improving Access to Self-Expanding Metal Stents for Patients With Esophageal Cancer in Eastern Africa: A Stepwise Implementation Strategy
- PMID: 33449802
- PMCID: PMC8081508
- DOI: 10.1200/GO.20.00318
Improving Access to Self-Expanding Metal Stents for Patients With Esophageal Cancer in Eastern Africa: A Stepwise Implementation Strategy
Abstract
Purpose: The eastern corridor of Africa is affected by a high burden of esophageal cancer (EC), with > 90% of patients presenting with advanced disease. Self-expanding metal stents (SEMS) have been previously reported as safe and effective for palliation of malignant dysphagia in resource-limited settings; however, access is limited throughout Eastern Africa.
Methods: In response to demand for palliative interventions for patients with dysphagia because of EC, the African Esophageal Cancer Consortium (AfrECC) partnered with the Clinton Health Access Initiative to improve access to SEMS in Eastern Africa. We undertook a stepwise implementation approach to (1) identify barriers to SEMS access, (2) conduct a market analysis, (3) select an industry partner, (4) establish regulatory and procurement processes, (5) develop endoscopic training resources, (6) create a medical device registry, and (7) establish principles of accountability.
Results: Following an evaluation of market demand and potential SEMS manufacturers, Boston Scientific Corporation announced its commitment to launch an access program to provide esophageal SEMS to patients in Tanzania, Kenya, Malawi, and Zambia at a subsidized price. Parallel regulatory and procurement processes were established in each participating country. Endoscopy training courses were designed and conducted, using the Training-of-Trainers model. A device registry was created to centralize data for quality control and to monitor channels of SEMS distribution. Principles of accountability were developed to guide the sustainability of this endeavor.
Conclusion: The AfrECC Stent Access Initiative is an example of a multisector partnership formed to provide an innovative solution to align regional needs with a supply chain for a high-priority medical device.
Conflict of interest statement
Beatrice P. Mushi
Michael M. Mwachiro
Geoffrey Buckle
Paul Kelly
Msiba Selekwa
Mark D. Topazian
David E. Fleischer
Katherine Van Loon
No other potential conflicts of interest were reported.
Figures


Similar articles
-
Treatment outcomes of esophageal cancer in Eastern Africa: protocol of a multi-center, prospective, observational, open cohort study.BMC Cancer. 2022 Jan 19;22(1):82. doi: 10.1186/s12885-021-09124-5. BMC Cancer. 2022. PMID: 35045815 Free PMC article.
-
Self-expanding metal stents (SEMS) for patients with advanced esophageal cancer in Malawi: an effective palliative treatment.J Surg Oncol. 2012 Mar 15;105(4):410-4. doi: 10.1002/jso.23003. Epub 2011 Dec 12. J Surg Oncol. 2012. PMID: 22161968
-
Quality of life in patients with esophageal stenting for the palliation of malignant dysphagia.World J Gastroenterol. 2011 Jan 14;17(2):144-50. doi: 10.3748/wjg.v17.i2.144. World J Gastroenterol. 2011. PMID: 21245986 Free PMC article. Review.
-
Self-expanding metal stents in palliation of malignant dysphagia: outcome of 124 Egyptian patients.Eur Arch Otorhinolaryngol. 2010 Jul;267(7):1123-7. doi: 10.1007/s00405-009-1198-y. Epub 2010 Jan 13. Eur Arch Otorhinolaryngol. 2010. PMID: 20069308
-
Anti-reflux versus conventional self-expanding metal stents in the palliation of esophageal cancer: A systematic review and meta-analysis.Endosc Int Open. 2022 Oct 17;10(10):E1406-E1416. doi: 10.1055/a-1894-0914. eCollection 2022 Oct. Endosc Int Open. 2022. PMID: 36262514 Free PMC article. Review.
Cited by
-
Treatment outcomes of esophageal cancer in Eastern Africa: protocol of a multi-center, prospective, observational, open cohort study.BMC Cancer. 2022 Jan 19;22(1):82. doi: 10.1186/s12885-021-09124-5. BMC Cancer. 2022. PMID: 35045815 Free PMC article.
-
Using context-specific evidence to inform resource-stratified cancer guidelines: A call for a new approach.Cancer. 2025 Jan 1;131(1):e35573. doi: 10.1002/cncr.35573. Epub 2024 Sep 22. Cancer. 2025. PMID: 39306723 Free PMC article.
-
Multisector Collaborations and Global Oncology: The Only Way Forward.JCO Glob Oncol. 2021 Jan;7:153-161. doi: 10.1200/GO.20.00492. JCO Glob Oncol. 2021. PMID: 33493021 Free PMC article.
-
A roadmap to establishing global oncology as a priority initiative within a National Cancer Institute-designated cancer center.J Natl Cancer Inst. 2024 Mar 7;116(3):345-351. doi: 10.1093/jnci/djad255. J Natl Cancer Inst. 2024. PMID: 38060289 Free PMC article. Review.
-
Expanding oesophageal cancer research and care in eastern Africa.Nat Rev Cancer. 2022 May;22(5):253-254. doi: 10.1038/s41568-022-00458-1. Nat Rev Cancer. 2022. PMID: 35246668 Free PMC article. No abstract available.
References
-
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 686:394-424, 2018 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical